Oculomotor dysfunction in amyotrophic lateral sclerosis: A comprehensive review

Archives of Neurology

Volumn 68, Issue 7, 2011, Pages 857-861

  Sharma, Rakesh ^a   Hicks, Stephen ^a   Berna, Claire M ^a   Kennard, Christopher ^a   Talbot, Kevin ^a   Turner, Martin R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; BELL PALSY; DISEASE COURSE; EYE MOVEMENT CONTROL; EYE MOVEMENT DISORDER; FRONTOTEMPORAL DEMENTIA; HUMAN; MONITORING; NEUROPSYCHOLOGICAL TEST; NYSTAGMUS; OPHTHALMOPLEGIA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SACCADIC EYE MOVEMENT; SURVIVAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; NEURAL PATHWAYS; OCULAR MOTILITY DISORDERS;

EID: 79960177202     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.130     Document Type: Review

References (50)

1. Ludolph AC, Langen KJ, Regard M, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand. 1992;85(2):81-89.
2. Abrahams S, Goldstein LH, Kew JJ, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis: a PET study. Brain. 1996;119(pt 6):2105-2120.
3. Turner MR, Cagnin A, Turkheimer FE, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15(3):601-609. (Pubitemid 38429975)
4. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60(7):1094-1097. (Pubitemid 36418766)
5. Segraves MA, Goldberg ME. Functional properties of corticotectal neurons in the monkey's frontal eye field. J Neurophysiol. 1987;58(6):1387-1419. (Pubitemid 18023466)
6. Paré M, Wurtz RH. Progression in neuronal processing for saccadic eye movements from parietal cortex area lip to superior colliculus. J Neurophysiol. 2001;85(6):2545-2562. (Pubitemid 32525532)
7. Schall JD, Thompson KG. Neural selection and control of visually guided eye movements. Annu Rev Neurosci. 1999;22:241-259. (Pubitemid 29144888)
8. Hikosaka O, Wurtz RH. Modification of saccadic eye movements by GABA-related substances, II: effects of muscimol in monkey substantia nigra pars reticulata. J Neurophysiol. 1985;53(1):292-308. (Pubitemid 15174289)
9. Kita H. GABAergic circuits of the striatum. In: Arbuthnott GW, Emson PC, eds. Chemical Signalling in the Basal Ganglia. Amsterdam, the Netherlands: Elsevier; 1993:51-72. (Pubitemid 24015886)
10. Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev. 2000;80(3):953-978. (Pubitemid 30452008)
11. Stanton GB, Goldberg ME, Bruce CJ. Frontal eye field efferents in the macaque monkey, I: subcortical pathways and topography of striatal and thalamic terminal fields. J Comp Neurol. 1988;271(4):473-492.
12. Shook BL, Schlag-Rey M, Schlag J. Primate supplementary eye field, II: comparative aspects of connections with the thalamus, corpus striatum, and related forebrain nuclei. J Comp Neurol. 1991;307(4):562-583.
13. Selemon LD, Goldman-Rakic PS. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci. 1985;5(3):776-794. (Pubitemid 15100467)
14. Leigh RJ, Kennard C. Using saccades as a research tool in the clinical neurosciences. Brain. 2004;127(pt 3):460-477. (Pubitemid 38295465)
15. Radcliffe CB, Lockhart Clarke J. An important case of paralysis and muscular atrophy with disease of the nervous centres. Br Foreign Med-Chir Rev. 1862:30.
16. Toyokura Y. Negative features in ALS. In: Tsubaki T, Toyokura Y, eds. Amyotrophic Lateral Sclerosis. Baltimore, MD: University Park Press; 1979:53-58.
17. Gregory R, Mills K, Donaghy M. Progressive sensory nerve dysfunction in amyotrophic lateral sclerosis: a prospective clinical and neurophysiological study. J Neurol. 1993;240(5):309-314. (Pubitemid 23202744)
18. Andersen PM, Forsgren L, Binzer M, et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation: a clinical and genealogical study of 36 patients. Brain. 1996;119(pt 4):1153-1172. (Pubitemid 26300718)
19. Mizutani T, Aki M, Shiozawa R, et al. Development of ophthalmoplegia in amyotrophic lateral sclerosis during long-term use of respirators. J Neurol Sci. 1990;99(2-3):311-319. (Pubitemid 20387387)
20. Martin JE, Swash M. Alternative approaches to the pathology of motor neuron disease. In: Leigh PN, Swash M, eds. Motor Neuron Disease Biology & Management. London, UK: Springer-Verlag; 1995:128-131.
21. Okamoto K, Hirai S, Amari M, et al. Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathol. 1993;85(5):458-462. (Pubitemid 23180405)
22. Nimchinsky EA, Young WG, Yeung G, et al. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. J Comp Neurol. 2000;416(1):112-125.
23. Haenggeli C, Kato AC. Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration. Neurosci Lett. 2002;335(1):39-43. (Pubitemid 35379810)
24. Whitehouse PJ, Wamsley JK, Zarbin MA, Price DL, Kuhar MJ. Neurotransmitter receptors in amyotrophic lateral sclerosis: possible relationship to sparing of eye movements. Ann Neurol. 1985;17(5):518.
25. Eisen A. Amyotrophic lateral sclerosis: evolutionary and other perspectives. Muscle Nerve. 2009;40(2):297-304.
26. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65(suppl 1):S3-S9.
27. Ince P, Stout N, Shaw P, et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol. 1993;19(4):291-299. (Pubitemid 23237479)
28. Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol. 1994;36(6):846-858. (Pubitemid 24370923)
29. Ho BK, Alexianu ME, Colom LV, Mohamed AH, Serrano F, Appel SH. Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proc Natl Acad Sci U S A. 1996;93(13):6796-6801.
30. Mosier DR, Siklós L, Appel SH. Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera. Neurology. 2000;54(1):252-255. (Pubitemid 30038776)
31. Vanselow BK, Keller BU. Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease. J Physiol. 2000;525(pt 2):433-445. (Pubitemid 30398372)
32. Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grisé D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38(6):734-747. (Pubitemid 30109452)
33. Maekawa S, Al Sarraj S, Kibble M, et al. Cortical selective vulnerability in motor neuron disease: a morphometric study. Brain. 2004;127(6):1237-1251. (Pubitemid 38745505)
34. Boxer AL, Garbutt S, Rankin KP, et al. Medial versus lateral frontal lobe contributions to voluntary saccade control as revealed by the study of patients with frontal lobe degeneration. J Neurosci. 2006;26(23):6354-6363.
35. Van Bogaert L. Contribution a la connaissance des troubles oculaires et vestibulaires dans la sclerose laterale amyotrophique. Rev Oto-neurooculist. 1925;3:263-274.
36. Lawyer T Jr, Netsky MG. Amyotrophic lateral sclerosis. AMA Arch Neurol Psychiatry. 1953;69(2):171-192.
37. Hayashi H, Kato S. Total manifestations of amyotrophic lateral sclerosis: ALS in totally locked-in state. J Neurol Sci. 1989;93(1):19-35. (Pubitemid 19244005)
38. Spooner JW, Sakala SM, Baloh RW. Effect of aging on eye tracking. Arch Neurol. 1980;37(9):575-576. (Pubitemid 10059171)
39. Jacobs L, Bozian D, Heffner RR Jr, Barron SA. An eye movement disorder in amyotrophic lateral sclerosis. Neurology. 1981;31(10):1282-1287. (Pubitemid 11026846)
40. Averbuch-Heller L, Helmchen C, Horn AK, Leigh RJ, Büttner-Ennerver JA. Slow vertical saccades in motor neuron disease: correlation of structure and function. Ann Neurol. 1998;44(4):641-648. (Pubitemid 28477852)
41. Moon SY, Lee BH, Seo SW, Kang SJ, Na DL. Slow vertical saccades in the frontotemporal dementia with motor neuron disease. J Neurol. 2008;255(9):1337-1343.
42. Gizzi M, DiRocco A, Sivak M, Cohen B. Ocular motor function in motor neuron disease. Neurology. 1992;42(5):1037-1046.
43. Shaunak S, Orrell RW, O'Sullivan E, et al. Oculomotor function in amyotrophic lateral sclerosis: evidence for frontal impairment. Ann Neurol. 1995;38(1):38-44.
44. Donaghy C, Pinnock R, Abrahams S, et al. Ocular fixation instabilities in motor neurone disease: a marker of frontal lobe dysfunction? J Neurol. 2009;256(3):420-426.
45. Donaghy C, Pinnock R, Abrahams S, et al. Slow saccades in bulbar-onset motor neurone disease. J Neurol. 2010;257(7):1134-1140.
46. Boisseau RL, Brissard ER. Un cas de sclerose laterale amyotrophique avec secousses nystagmiformes. Rev Otoneuroophtalmol. 1932;10:257-260.
47. Kushner MJ, Parrish M, Burke A, et al. Nystagmus in motor neuron disease: clinicopathological study of two cases. Ann Neurol. 1984;16(1):71-77. (Pubitemid 14084136)
48. Esteban A, De Andrés C, Giménez-Roldán S. Abnormalities of Bell's phenomenon in amyotrophic lateral sclerosis: a clinical and electrophysiological evaluation. J Neurol Neurosurg Psychiatry. 1978;41(8):690-698. (Pubitemid 8372360)
49. Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129(pt 9):2436-2446. (Pubitemid 44522128)
50. Grosskreutz J, Van Den Bosch L, Keller BU. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47(2):165-174.